KARA TOOLEY: Open Payments
NPI 1699396093 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 32 payments from 10 companies in 2025. Trend: 2023 $1,064 · 2024 $759 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $384 |
| GlaxoSmithKline, LLC. | 13 | $210 |
| GENZYME CORPORATION | 4 | $202 |
| AstraZeneca Pharmaceuticals LP | 4 | $181 |
| Insmed, Inc. | 2 | $53 |
| Grifols USA, LLC | 1 | $33 |
| Electromed, Inc. | 1 | $32 |
| Baxter Healthcare | 1 | $26 |
| Lilly USA, LLC | 1 | $21 |
| Verona Pharma, Inc. | 1 | $18 |
Products named: OFEV, DUPIXENT, NUCALA, BREZTRI, TEZSPIRE, TRELEGY ELLIPTA, Prolastin-C Liquid, SMARTVEST.
Industry payments across AL — which companies pay providers there.
